top of page

Our Mission

MATE Bioservices originated as a University of California San Francisco spin-off aimed at harnessing the power of SPOKE. Our objective is to support academic, clinical, and pharmaceutical researchers in their efforts to better understand diseases, biological complexity, and bring new products to the market.

SPOKE

At the core of Mate’s technology is the Scalable Precision Medicine Knowledge Engine (SPOKE), a “database of databases” that integrates existing biomedical knowledge into a graph database developed at the University of California, San Francisco (UCSF). The scope of SPOKE is unlike any graph currently available to consumers. It intelligently brings together information at the smallest (molecular) to largest (phenotypic) levels. Together with our proprietary algorithms, Mate’s base platform (BRIC) crosses disciplines to bring researchers the information they need instantly and interpret their data in a multi-domain fashion. 

SPOKE MetaGraph

12K

700

2K

4K

4K

15K

102

13K

54

2K

2M

11K

8K

14K

600

10K

20K

20K

39M

6K

300K

2K

Explore under the hood

Although an  enormous body  information has been produced to date in the biomedical field , the vast complexity and  has made difficult to generate usable knowledge that takes into account all multivariate interactions.

 

Unsuccessful attempts have been made to establish interconnection between biomedical data, mainly focusing on the algorithms.

Our multidisciplinary team integrated by physicians, biochemists, pharmacologists .drug developers and computer specialist took a different approach. Starting from the understanding of the underlying biologic mechanisms we designed a system focused on the users: Scientists involved in drug discovery and development.

 

This unique expertise allows us to support our partners on their drug development efforts by speaking their same language and being able to process the information in our labs.

Experience the difference

Publications

Embedding electronic health records onto a knowledge network recognizes prodromal features of multiple sclerosis and predicts diagnosis

MS
bottom of page